IL1B and hepatocellular carcinoma: A Asian-Korean study suggested that IL1B SNPs rs1143633 (A>G) and rs1143627 (T>C) protected against hepatocellular carcinoma [dominant model: OR (95% CI) = 0.59 (0.37–0.94), P = 0.027; dominant model: OR (95% CI) = 0.56 (0.34–0.91), P = 0.019] and IL1B SNP rs3917356 (G>A) increased the risk of hepatocellular carcinoma [recessive model: OR (95% CI) = 2.58 (1.53–4.33), P < 0.001]9.